Search results
Showing results for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Introducing the Mechanical Workshop
21 June 2022
This month we speak to John Prentice, manager of the Mechanical Workshop in the Department of Oncology. The workshop supports a wide range of research projects within the Medical Sciences Division and is also available to groups within the wider University community.
Clinical trials for a malaria vaccine start in Mali and Indonesia
21 June 2022
Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.
Researchers discover novel form of adaptation in the auditory system
21 June 2022
Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have found that the auditory system adapts to the changing acoustics of reverberant environments by temporally shifting the inhibitory tuning of cortical neurons to remove reverberation.
20 minutes of daily exercise can keep teens' doctors away
20 June 2022
Teenagers should exercise vigorously for at least 20 minutes per day to reap increased cardiorespiratory fitness (CRF), according to a cross-sectional study from the UK led by University of Oxford researchers.
Mechanism of expanding bacteria revealed
20 June 2022
A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.
Oxford to receive £7 million to turn bright ideas into global opportunities
15 June 2022
The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from UK research institutions.
Discovery of gene involved in chronic pain creates new treatment target
15 June 2022
Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.
Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics
14 June 2022
A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.
Biological processes of ageing is key to improving later life health
9 June 2022
Improvements in health care, sanitation, and diet over last 100 years have significantly increased life expectancy. However, this increase in how long we can expect to live has not been accompanied by a similar increase in healthy life expectancy, defined as the time spent free of major illness or disease.
Multiple heart-related conditions linked to triple dementia risk regardless of genetics
9 June 2022
Having multiple conditions that affect the heart are linked to a greater risk of dementia than having high genetic risk, according to a largescale new study co-led by the University of Oxford.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
9 June 2022
People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have been more at risk of dying or needing hospital care if they got COVID-19 before vaccination compared with the general population, according to a new study published in The Lancet Rheumatology with the involvement of researchers from the University of Oxford.
Queen’s Birthday Honours recognise service from Vice-Chancellor and Oxford colleagues
7 June 2022
Members of the University have been recognised in the 2022 Queen's Birthday Honours List, including scientists from across the Medical Sciences Division.
Collaborative team driven by DPAG and Chemistry awarded RSC Horizon Prize
7 June 2022
The Molecular Flow Sensor Team, with collaborating members principally from DPAG’s Robbins and Talbot groups and the Department of Chemistry, has been named the winner of the Royal Society of Chemistry’s (RSC) Analytical Division Horizon Prize for the development of a new technology for measuring lung function.
Oxford expands the Cartography collaboration with Janssen
6 June 2022
The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation
Doctoral research funding initiative launched to tackle antimicrobial resistance
1 June 2022
Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.
Museum of Natural History to showcase Science Together community-researcher collaborations
1 June 2022
Explore Science Together event at the Oxford University Museum of Natural History on Tuesday 7 June.
Long COVID: vaccination could reduce symptoms, new research suggests
27 May 2022
While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.
Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds
26 May 2022
Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.
Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
24 May 2022
COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.